Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 23;46(9):9286-9297.
doi: 10.3390/cimb46090549.

Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review

Affiliations

Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review

Beatriz Pérez-Peláez et al. Curr Issues Mol Biol. .

Abstract

Myeloid-derived suppressor cells (MDSCs) are immature cells with an immunosuppressive function. MDSCs have been related to inflammation in many settings, including infections, transplantation, obesity, aging, or cancer. In oncological settings, MDSCs participate in tumor immunoescape, growth, and metastasis. Certain nutrients can modify chronic inflammation by their interaction with MDSCs. Therefore, the possible influence of certain nutrients on immune surveillance by their actions on MDSCs and how this may affect the prognosis of cancer patients were evaluated in this scoping review. We identified seven papers, six of which were murine model studies and only one was a human clinical trial. Globally, a significant reduction in cancer growth and progression was observed after achieving a reduction in both MDSCs and their immunosuppressive ability with nutrients such as selected vegetables, icaritin, retinoic acid, curdlan, active vitamin D, soy isoflavones, and green tea. In conclusion, the consumption of certain nutrients may have effects on MDSCs, with beneficial results not only in the prevention of tumor development and growth but also in improving patients' response.

Keywords: cancer; dietary supplements; myeloid-derived suppressor cells; neoplasms; nutrients; vitamins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Article selection process according to the PRISMA guidelines.

Similar articles

Cited by

References

    1. Chesney J.A., Mitchell R.A., Yaddanapudi K. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J. Leukoc. Biol. 2017;102:727–740. doi: 10.1189/jlb.5VMR1116-458RRR. - DOI - PMC - PubMed
    1. Veglia F., Sanseviero E., Gabrilovich D.I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 2021;21:485–498. doi: 10.1038/s41577-020-00490-y. - DOI - PMC - PubMed
    1. Talmadge J.E., Gabrilovich D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer. 2013;13:739–752. doi: 10.1038/nrc3581. - DOI - PMC - PubMed
    1. Hofer F., Di Sario G., Musiu C., Sartoris S., De Sanctis F., Ugel S. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment. Cells. 2021;10:2700. doi: 10.3390/cells10102700. - DOI - PMC - PubMed
    1. Trovato R., Cane S., Petrova V., Sartoris S., Ugel S., De Sanctis F. The Engagement Between MDSCs and Metastases: Partners in Crime. Front. Oncol. 2020;10:165. doi: 10.3389/fonc.2020.00165. - DOI - PMC - PubMed

Publication types

LinkOut - more resources